FENNEC PHARMACEUTICALS INC. — Form D
FENNEC PHARMACEUTICALS INC. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-08. The offering totals $7.6M, of which $7.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-08
- Form: D
- Accession: 0001478689-17-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.6M
- Amount sold: $7.6M
- Investors: 7
- Date of first sale: 2017-06-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-288353
Issuer
- Name: FENNEC PHARMACEUTICALS INC.
- CIK: 0001211583
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: (919) 636-4530
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Adrian Haigh | Director | RESEARCH TRIANGLE PARK, NC |
| Khalid Islam | Director | RESEARCH TRIANGLE PARK, NC |
| Chris Rallis | Director | RESEARCH TRIANGLE PARK, NC |
| Rostislav Raykov | Director | Toronto, A6 |
| Steven Skolsky | Director | RESEARCH TRIANGLE PARK, NC |
| Krysia Lynes | Executive Officer | RESEARCH TRIANGLE PARK, NC |
| Rostislav Raykov | Executive Officer | Toronto, A6 |
| Chris A Rallis | Director | Morrisville, NC |
| Rotislav Raykov | Director | RESEARCH TRIANGLE PARK, NC |
| Rotislav Raykov | Executive Officer | RESEARCH TRIANGLE PARK, NC |
Other filings by this issuer (2)
More